vs
BIOCRYST PHARMACEUTICALS INC（BCRX）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
Rackspace Technology, Inc.的季度营收约是BIOCRYST PHARMACEUTICALS INC的1.7倍（$682.8M vs $406.6M），BIOCRYST PHARMACEUTICALS INC净利率更高（60.5% vs -4.8%，领先65.3%），BIOCRYST PHARMACEUTICALS INC同比增速更快（209.1% vs -0.4%），BIOCRYST PHARMACEUTICALS INC自由现金流更多（$291.2M vs $56.0M），过去两年BIOCRYST PHARMACEUTICALS INC的营收复合增速更高（109.4% vs -0.6%）
BioCryst Pharmaceuticals是一家总部位于美国北卡罗来纳州达勒姆的制药企业，属于后期发展阶段的生物科技公司，聚焦于治疗罕见重症的口服药物研发。其研发的抗病毒药物帕拉米韦（商品名Rapivab）于2014年12月获得美国FDA批准，此后也陆续在日本、韩国与中国获批上市。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
BCRX vs RXT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.6M | $682.8M |
| 净利润 | $245.8M | $-32.7M |
| 毛利率 | 97.7% | 17.6% |
| 营业利润率 | 64.0% | -0.5% |
| 净利率 | 60.5% | -4.8% |
| 营收同比 | 209.1% | -0.4% |
| 净利润同比 | 1017.5% | 41.6% |
| 每股收益（稀释后） | $1.13 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $406.6M | $682.8M | ||
| Q3 25 | $159.4M | $671.2M | ||
| Q2 25 | $163.4M | $666.3M | ||
| Q1 25 | $145.5M | $665.4M | ||
| Q4 24 | $131.5M | $685.6M | ||
| Q3 24 | $117.1M | $675.8M | ||
| Q2 24 | $109.3M | $684.9M | ||
| Q1 24 | $92.8M | $690.8M |
| Q4 25 | $245.8M | $-32.7M | ||
| Q3 25 | $12.9M | $-67.1M | ||
| Q2 25 | $5.1M | $-54.5M | ||
| Q1 25 | $32.0K | $-71.5M | ||
| Q4 24 | $-26.8M | $-56.0M | ||
| Q3 24 | $-14.0M | $-186.6M | ||
| Q2 24 | $-12.7M | $25.0M | ||
| Q1 24 | $-35.4M | $-640.6M |
| Q4 25 | 97.7% | 17.6% | ||
| Q3 25 | 98.6% | 19.4% | ||
| Q2 25 | 98.3% | 19.4% | ||
| Q1 25 | 96.9% | 19.1% | ||
| Q4 24 | 95.4% | 19.2% | ||
| Q3 24 | 97.3% | 20.3% | ||
| Q2 24 | 98.4% | 19.2% | ||
| Q1 24 | 98.6% | 19.2% |
| Q4 25 | 64.0% | -0.5% | ||
| Q3 25 | 18.6% | -5.1% | ||
| Q2 25 | 18.2% | -3.8% | ||
| Q1 25 | 14.6% | -5.8% | ||
| Q4 24 | -3.4% | -4.2% | ||
| Q3 24 | 6.6% | -25.7% | ||
| Q2 24 | 8.0% | -7.9% | ||
| Q1 24 | -15.6% | -94.5% |
| Q4 25 | 60.5% | -4.8% | ||
| Q3 25 | 8.1% | -10.0% | ||
| Q2 25 | 3.1% | -8.2% | ||
| Q1 25 | 0.0% | -10.7% | ||
| Q4 24 | -20.4% | -8.2% | ||
| Q3 24 | -12.0% | -27.6% | ||
| Q2 24 | -11.6% | 3.7% | ||
| Q1 24 | -38.1% | -92.7% |
| Q4 25 | $1.13 | $-0.13 | ||
| Q3 25 | $0.06 | $-0.28 | ||
| Q2 25 | $0.02 | $-0.23 | ||
| Q1 25 | $0.00 | $-0.31 | ||
| Q4 24 | $-0.13 | $-0.20 | ||
| Q3 24 | $-0.07 | $-0.82 | ||
| Q2 24 | $-0.06 | $0.11 | ||
| Q1 24 | $-0.17 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $274.7M | $105.8M |
| 总债务越低越好 | — | $2.7B |
| 股东权益账面价值 | $-119.2M | $-1.2B |
| 总资产 | $514.2M | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $274.7M | $105.8M | ||
| Q3 25 | $212.9M | $99.5M | ||
| Q2 25 | $260.0M | $103.9M | ||
| Q1 25 | $295.1M | $128.0M | ||
| Q4 24 | $320.9M | $144.0M | ||
| Q3 24 | $96.8M | $157.1M | ||
| Q2 24 | $78.4M | $190.2M | ||
| Q1 24 | $84.3M | $282.6M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $3.0B |
| Q4 25 | $-119.2M | $-1.2B | ||
| Q3 25 | $-387.9M | $-1.2B | ||
| Q2 25 | $-421.6M | $-1.1B | ||
| Q1 25 | $-451.9M | $-1.1B | ||
| Q4 24 | $-475.9M | $-1.0B | ||
| Q3 24 | $-468.6M | $-949.7M | ||
| Q2 24 | $-475.6M | $-756.2M | ||
| Q1 24 | $-476.2M | $-787.2M |
| Q4 25 | $514.2M | $2.8B | ||
| Q3 25 | $446.4M | $2.8B | ||
| Q2 25 | $457.2M | $2.9B | ||
| Q1 25 | $480.0M | $3.0B | ||
| Q4 24 | $490.4M | $3.1B | ||
| Q3 24 | $491.3M | $3.1B | ||
| Q2 24 | $472.4M | $3.4B | ||
| Q1 24 | $467.9M | $3.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $292.0M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $291.2M | $56.0M |
| 自由现金流率自由现金流/营收 | 71.6% | 8.2% |
| 资本支出强度资本支出/营收 | 0.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.19× | — |
| 过去12个月自由现金流最近4个季度 | $344.9M | $90.6M |
8季度趋势，按日历期对齐
| Q4 25 | $292.0M | $59.7M | ||
| Q3 25 | $41.6M | $70.7M | ||
| Q2 25 | $41.3M | $8.4M | ||
| Q1 25 | $-27.5M | $12.6M | ||
| Q4 24 | $-5.2M | $54.3M | ||
| Q3 24 | $8.2M | $51.8M | ||
| Q2 24 | $-1.4M | $24.1M | ||
| Q1 24 | $-53.7M | $-90.3M |
| Q4 25 | $291.2M | $56.0M | ||
| Q3 25 | $40.3M | $42.7M | ||
| Q2 25 | $41.1M | $-12.4M | ||
| Q1 25 | $-27.7M | $4.3M | ||
| Q4 24 | $-5.9M | $34.4M | ||
| Q3 24 | $8.2M | $27.3M | ||
| Q2 24 | $-1.5M | $-14.5M | ||
| Q1 24 | $-53.9M | $-118.4M |
| Q4 25 | 71.6% | 8.2% | ||
| Q3 25 | 25.3% | 6.4% | ||
| Q2 25 | 25.2% | -1.9% | ||
| Q1 25 | -19.0% | 0.6% | ||
| Q4 24 | -4.5% | 5.0% | ||
| Q3 24 | 7.0% | 4.0% | ||
| Q2 24 | -1.4% | -2.1% | ||
| Q1 24 | -58.1% | -17.1% |
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.8% | 4.2% | ||
| Q2 25 | 0.1% | 3.1% | ||
| Q1 25 | 0.1% | 1.2% | ||
| Q4 24 | 0.5% | 2.9% | ||
| Q3 24 | 0.1% | 3.6% | ||
| Q2 24 | 0.1% | 5.6% | ||
| Q1 24 | 0.3% | 4.1% |
| Q4 25 | 1.19× | — | ||
| Q3 25 | 3.23× | — | ||
| Q2 25 | 8.12× | — | ||
| Q1 25 | -859.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCRX
暂无分部数据
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
